The leadership change at Cano Health may have a neutral short-term impact on the stock price. While the appointment of an interim CEO and the search for a permanent CEO may create some uncertainty, the company's commitment to refreshing the board with new independent directors could be seen as a positive move towards better corporate governance. The overall impact is neutral as the market may wait for more information on the new CEO and the refreshed board before reacting.